We require Idiopathic Pulmonary Fibrosis (IPF) patients who also have a diagnosis of Obstructive Sleep Apnoea (OSA) for a new study.
This study will be 2 to 3 visits to the unit, and will be spread over approximately 1 to 4 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require Idiopathic Pulmonary Fibrosis (IPF) patients for a new study.
This study will be 2 to 4 visits to the unit and two phone calls, and will be spread over approximately 4 to 8 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require mild asthmatics for a new study.
This study will be approximately 9 visits to the unit, including 7 one-night residential stays and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require both male and female psoriasis patients between the ages of 18 and 65 for a new study. This study will be approximately 3 visits to the unit, including one 19 night stay at the clinical trial unit and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require both male and female healthy volunteers between the ages of 18 and 65 for a new study.
This study will be approximately 3 visits to the unit, including one 19 night stay at the clinical trial unit and will be spread over approximately 4-11 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require asthma patients for a new study.
This study will be approximately 10 visits to the unit and 1 phone contact, and will spread over approximately 14 months.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
You can feel proud in the knowledge that your participation will be helping The MEU to develop new treatments for future generations. Your time and commitment is also recognised in the following ways:
A leading specialist clinical research facility working with the pharmaceutical industry to identify potential new treatments for conditions such as Asthma, Bronchitis and Emphysema and now many more therapeutic areas.
We at the MEU want to deliver rewarding research to improve clinical care whilst also rewarding our volunteers for their continued support.
Contact us…
The Medicines Evaluation Unit
The Langley Building
Southmoor Road
Wythenshawe Hospital
Manchester
M23 9QZ
T: 0800 655 6553
